The nucleic acid and amino acid sequence data were deposited in EMBL/GenBank/DDBJ under accession numbers AJ505027 to AJ505034 (Sc:-1,-2,-3 allele), AJ505035 to AJ505042 (Sc2 allele) and AJ505043 to AJ505050 (Rd allele). allele. Scianna is the last of the previously characterized protein based blood group systems whose molecular basis was discerned. Hence, the phenotype prediction by genotyping became possible for all human blood group systems encoded by proteins.
Introduction
The molecular characterization of polymorphism underlying blood group antigens has made enormous advances during the last 15 years 1 . Currently, 26 blood group systems are recognized 2 . The antigens of 22 blood group systems are determined by epitopes on proteins.
They may function as transport or adhesion proteins, ectoenzymes, or cytokine receptors present on the red blood cells (RBCs) surface 1 . Most recently, the DOK1 gene determining the Dombrock blood group system (ISBT 014) had been characterized 3 , leaving Scianna (ISBT 013) the last protein-based blood group system whose molecular basis remained obscure.
The Scianna blood group system comprises two antithetical antigens, the high-frequency rare Sc:-1,-2 phenotype, three clusters of which were observed in circumscribed populations 5 .
The Scianna antigens were shown to reside on a "Scianna glycoprotein" of about 60-68 kD 6 . Scianna antigens were inherited linked to the RH antigens, but shown to be distinct 7 . The latest data indicated a genomic position of 1p34 to 1p36 8 . A second low-frequency antigen, Rd (700.015) shared this position 9; 10 and was found on a protein of similar size 11 . Both anti-Sc2 12 and anti-Rd 13 are clinically relevant, having caused hemolytic disease of the newborn. The molecular basis and function of the Scianna blood group system and its glycoprotein remained unknown.
We demonstrated that the Scianna antigens are expressed by the red cell adhesion protein ERMAP. The polymorphism underlying the Sc2 and Rd antigens were determined. PCR-SSP methods that allow the genotypic prediction of these antigens were developed.
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Subjects and Methods
Rare Scianna phenotypes. Sc:2 and Rd+ blood samples were obtained from the SCARF exchange program. Sc:-1, 2 and Sc:-1,-2 samples were from the reference collection at the International Blood Group Reference Laboratory. The Sc:-1,-2 pedigree came from SaudiArabia. Control blood samples derived from South-Western German blood donors.
Nucleotide sequencing. Nucleotide sequencing was performed using Prism dye terminator cycle-sequencing kit with AmpliTaq FS DNA polymerase and Prism BigDye terminator cycle sequencing ready reaction kit (Applied Biosystems, Weiterstadt, Germany) with a DNA sequencing unit (ABI 3100, Applied Biosystems). Nucleotide sequencing of genomic DNA stretches representative for all eleven ERMAP exons and parts of the promoter was accomplished using primers (Table 1 ) and amplification procedures ( Table 2 ) that obviated the need for subcloning steps. PCR was performed using Expand high-fidelity PCR system or Expand long range PCR system (Boehringer Mannheim, Mannheim, Germany). Thermocycling conditions consisted of an initial denaturation of 2 min at 92 °C, followed by 45 cycles of 20 s denaturation at 92 °C, 30 s annealing at 60 °C and 10 min extension at 68 °C, with an incremental elongation of the extension time of 20 s for each cycle after cycle 10.
PCR-SSP. PCR -SSP methods were devised to detect the C/T polymorphism at nucleotide 54 (counted relative to the A of the start codon in the cDNA), the C/T polymorphism at position 76, the G/A polymorphism at position 169 causing the Sc1/Sc2 polymorphism and the G at position 178 in Rd (Table 3 ). The reactions were triggered to work under similar PCR conditions as a PCR-SSP system previously developed for RHD typing 14; 15 
PCR-RFLP.
The PCR product also used for exon 3 sequencing (Table 2 ) was digested for 3 h at 37°C with PvuII and SmaI (Pharmacia, Freiburg, Germany). In this assay, PvuII was added in addition to SmaI to ensure that the resulting fragments were in a size range that allowed easy distinction of fragments that were or were not cut by SmaI.
Population screen for ERMAP alleles. The prevalence of the 54 T/C and 76 T/C polymorphism were determined in 111 blood samples from blood donors in Baden-Württemberg (South-Western Germany) by PCR-SSP. Maximum-likelihood estimates of allele frequencies were calculated using the counting method 16 . The presence of ERMAP alleles representative of Sc2 and Rd was checked by PCR-SSP in 305 samples.
Modeling. The extent of the signal peptide was determined using Signal P V2.0 
Results
The chromosomal position of the ERMAP gene and the molecular weight of the encoded erythroid membrane-associated protein (ERMAP) matched the data closely that were previously established for the Scianna glycoprotein 22; 23 . These observations prompted us to explore whether ERMAP alleles were underlying the Scianna antigens.
A Sc:-1-2 proband is probably homozygous for a non-functional ERMAP allele. We determined the nucleotide sequence of the 11 ERMAP exons in a proband who lacked both the Sc1, Sc2 and Sc3 antigens (EMBL/GenBank/DDBJ accession numbers AJ505027 to AJ505034).
In exon 3, the ERMAP allele harbored a two base pair deletion that was possibly caused by a slippage error of the DNA polymerase in the "GAGAGA" repetitive sequence. This frameshift caused a truncated protein of 113 amino acids ( For personal use only. on April 14, 2017. by guest www.bloodjournal.org From phenotype were also encountered in control samples. Therefore, 111 blood donors were systematically checked for the presence of an ERMAP(H26Y) allele or a 54C>T polymorphism (Table 4) . Maximum likelihood estimates of the allele frequencies were derived. ERMAP(H26Y) occurred with a frequency of 0.33. The majority of these alleles (allele frequency 0.28) were predicted to carry a 54C>T substitution, too, while an ERMAP(H26Y) with the wild type C at position 54 occurred less frequently (allele frequency 0.05). In contrast, the ERMAP alleles encoding a histidine at position 26 carried a C at position 54 (allele frequency 0.67) and represented the wild type allele 22; 23 .
Modeling of the ERMAP immunoglobulin domain. Based on the known similarity of
ERMAP to immunoglobulin, we modeled the tertiary structure of the amino acids 46 to 131 representing part of the extracellular domain of ERMAP. The proline substituted in the Rd allele was exposed on the protein's surface. The amino acid causing the Sc1/Sc2 polymorphism was located in a pocket of the protein's surface thereby rendering it less accessible to antibodies.
However, the amino acids involved in the Sc2 polymorphism were predicted to alter the threedimensional structure of this extracellular domain considerably, which may explain the immunogenicity of the ERMAP polymorphism (Fig. 4) . Exon 5 ev4a en10r ev5a
Exon 6 ev4a en10r ev6a
Exon 7 ev4a en10r ev7a
Exon 8 ev4a en10r ev8a
Exon 9 ev4a en10r ev8a
Exon 10 ev4a en10r ev8a
Exon 11 ev11a en11a ev11b, ei11a ei11b, ei11c * Primer sequences are given in Table 1 . † For each sample, one or more sequencing primers were used, if applicable.
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